XML 116 R41.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock-based Compensation (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Restricted Stock Units (RSUs)        
Share-based Payment activity [Roll Forward]        
Unvested at beginning of period (in shares) 990,100 841,300 841,300  
Granted (in shares) 0 0    
Vested (in shares) (191,500) (145,600)    
Forfeited (in shares) (22,600) (7,300)    
Unvested at end of period (in shares) 776,000.0 688,400 990,100 841,300
Performance Shares [Member]        
Share-based Payment activity [Roll Forward]        
Unvested at beginning of period (in shares) 458,100 567,000.0 567,000.0  
Granted (in shares) 900 31,000.0    
Vested (in shares) (109,000.0) (257,200)    
Forfeited (in shares) (6,500) (24,400)    
Unvested at end of period (in shares) 343,500 316,400 458,100 567,000.0
Share-based Payment Arrangement [Member]        
Share-based Payment activity [Roll Forward]        
Unvested at beginning of period (in shares) 1,448,200 1,408,300 1,408,300  
Granted (in shares) 900 31,000.0    
Vested (in shares) (300,500) (402,800)    
Forfeited (in shares) (29,100) (31,700)    
Unvested at end of period (in shares) 1,119,500 1,004,800 1,448,200 1,408,300
Share-based Payment activity, additional disclosures [Abstract]        
Weighted average grant date fair value, beginning of period (in dollars per share) $ 175.07 $ 170.78 $ 170.78  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value 187.26 111.33    
Weighted average grant date fair value, vested (in dollars per share) 182.60 115.92    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 172.26 125.84    
Weighted average grant date fair value, end of period (in dollars per share) $ 172.40 $ 192.36 $ 175.07 $ 170.78
Weighted average remaining contractual life, unvested shares outstanding 1 year 3 months 18 days 1 year 7 months 28 days 1 year 7 months 28 days 1 year 9 months 14 days
Unamortized deferred compensation cost $ 61.0